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Higher Expression of Toll-Like 
Receptors 2 and 4 in Blood Cells of 
Keratoconus Patiens
Tomás Sobrino1, Uxía Regueiro1,2, Mercedes Malfeito1,2, Alba Vieites-Prado1, María Pérez-Mato1, 
Francisco Campos1 & Isabel Lema1,2,3
Inflammation may play a significant role in Keratoconus (KC), but the implication of immunity on this 
inflammatory response is unknown. Therefore, our aim was to determine the expression levels of Toll-
like receptors 2 (TLR2) and 4 (TLR4) in monocytes and neutrophils from patients with KC and control 
subjects for demonstrating the role of innate immunity in KC. We also study the correlation between 
TLR2/TLR4 expression and serum levels of proinflammatory markers (IL-1β, IL-6, TNF-α, MMP-9 and 
NF-κB). Forty patients with bilateral KC (55% males; mean age; 33.1 ± 10.9 years) and 20 control 
subjects (55% males; mean age; 30.4 ± 7.6 years) were included in the study. Our results showed that 
mean expression of TLR2 and TLR4 in both neutrophils and monocytes was significantly higher in 
patients with KC compared to control subjects (all p < 0.0001). Furthermore, KC patients also showed 
higher serum levels of IL-1B, IL-6, TNF-α, MMP-9 (all p < 0.0001) and NF-κB (p = 0.036). In addition, we 
found a strong correlation between TLR2 expression in both monocytes and neutrophils (all p < 0.0001), 
and TLR4 in monocytes (all p < 0.05) with serum levels of IL-1B, IL-6, TNF-α and MMP-9. In conclusion, 
these findings suggest that TLRs may play an important role in the pathophysiology of KC.
Keratoconus (KC) is a primary corneal ectasia, generally bilateral and progressive, in which the cornea assumes 
a conical shape as a result of the thinning of the corneal stroma. The corneal thinning induces irregular astigma-
tism, myopia and protrusion, leading to mild to marked impairment in the quality of vision1. On the other hand, 
the cornea is part of an integrated system, the ocular surface, which contains specific and non-specific immune 
molecules. In this regard, tissue degradation in thinning disorders as KC involves the expression of inflamma-
tory mediators, such as proinflammatory cytokines, cell adhesion molecules and matrix metalloproteinases2–4. 
Moreover, previous studies by our group have demonstrated that levels of pro-inflammatory cytokines, such as 
IL-6 and TNF-α, and matrix metalloproteinase-9 (MMP-9) are significantly increased in tears of patients with 
KC4,5. We also observed decreased levels of lactoferrin (Lf), zinc-α2-glycoprotein (ZAG), and immunoglobu-
lin kappa chain (IGKC) in the tears of patients with KC compared to control subjects6. All these molecules are 
involved in the immune response, so these results suggest that immunological processes may be involved in the 
pathogenesis of ectasias. In fact, Lf, at systemic and local level, modulates the function of humoral and cellular 
components of the innate and adaptive response via toll like receptors (TLRs)7,8. TLRs are a family of highly con-
served innate immunity receptors that recognize damage-associated molecular patterns from endogenous mole-
cules, which are released as a consequence of tissue damage9. These molecules, also known as endogenous ligands, 
are able to activate TLR promoting the recruitment of several adaptive proteins to activate nuclear factor-kB 
(NF-κB), which induces the expression of pro-inflammatory genes, inflammatory cytokines, and adhesion mole-
cules10. In this regard, previous studies by our group have demonstrated that inflammatory markers are associated 
with KC and subclinical KC4,5. Moreover, TLR4 is expressed in several eye tissues and cells, including corneal 
epithelial cells and fibroblasts of the corneal stroma. TLR2 is also expressed in human conjunctival epithelial 
cells8. Importantly, the treatment of corneal epithelial cells with neutralizing TLR2-antibodies induced a signifi-
cant decrease of IL-6, IL-8 and TNF-α11. Consequently, it is tempting to postulate that the inflammatory response 
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associated to KC could be a consequence of the TLR activation. However, the role of TLRs in KC patients has 
not yet been tested. Therefore, the purpose of this study was to measure expression levels of TLR2 and TLR4 in 
monocytes and neutrophils from KC patients and control subjects. In addition, we study the correlation between 
TLR2/TLR4 expression and serum levels of proinflammatory markers (IL-1B, IL-6, TNF-α, MMP-9 and NF-κB).
Results
We prospectively studied 40 patients with bilateral KC (55% male; mean age, 31.1 ± 10.9 years) and 20 control 
subjects (55% male; mean age, 30.4 ± 7.6 years). No age- and sex-related statistical differences were detected 
between patients with KC and control subjects. However, patients with KC showed more frequent family history 
of KC and allergic disease (Table 1). Twenty-four KC patients (60%) and 6 control subjects (30.0%) reported aller-
gic disease; and 10 KC patients (25%) but no control subjects a family history of KC.
The elapsed time from the first diagnosis of KC eye and the study ranged from 1 to 31 years (mean, 12.1 ± 9.7 
years). All KC patients showed moderate or severe stage of KC progression in the most affected eye: 17 eyes 
(42.5%) presented moderate KC (K2 between 45 D and 52 D); and 23 eyes (57.5%) had severe KC (K2 > 52 D). 
Moreover, Table 1 also shows the mean K2 and thinnest point values for the study groups. Mean K2 values were 
higher and mean thinnest point lower in the eyes with KC versus the control ones (p < 0.0001).
Expression of TLR2/TLR4 and proinflammatory molecules. Figure 1 shows that the mean expression 
of TLR2 and TLR4 in both neutrophils and monocytes was significantly higher in patients with KC compared to 
control subjects (all p < 0.0001) (Table 1). Moreover, KC patients had higher serum levels of IL-1B, IL-6, TNF-α, 
MMP-9 (all p < 0.0001) and NF-κB (p = 0.036) (Fig. 2) (Table 1). On the other hand, no TLR expression differ-
ences were observed between KC patients with and without allergic disease (TLR2 expression in neutrophils 
(759.1 ± 108.8 vs. 709.7 ± 108.3; p = 0.167); TLR2 expression in monocytes (3139.3 ± 715.5 vs. 2790.9 ± 557.8; 
p = 0.109); TLR4 expression in neutrophils (664.0 ± 120.4 vs. 674.8 ± 144.1; p = 0.800); TLR4 expression in 
monocytes (1574.8 ± 308.5 vs. 1621.7 ± 352.8; p = 0.659).
Correlation between the expression of TLR2/TLR4 and severity of KC. No association was found 
between the expression of TLR2 and TLR4 in both neutrophils and monocytes and the severity of the most 
affected eye with KC, evaluated by the steep keratometric reading (K2) and the thinnest point of the cornea.
Pearson coefficients for K2 were the following: TLR2 expression in neutrophils (r = 0.041; p = 0.800); TLR2 
expression in monocytes (r = −0.048; p = 0.767); TLR4 expression in neutrophils (r = 0.187; p = 0.249); and 
TLR4 expression in monocytes (r = 0.024; p = 0.882).
On the other hand, Pearson coefficients for the thinnest point of the cornea were the following: TLR2 expres-
sion in neutrophils (r = 0.173; p = 0.287); TLR2 expression in monocytes (r = 0.208; p = 0.198); TLR4 expression 
in neutrophils (r = −0.219; p = 0.175); and TLR4 expression in monocytes (r = −0.091; p = 0.576).
Finally, there was no association between the elapsed time from the first diagnosis of KC eye and the TLR2 and 
TLR4 expression in both neutrophils and monocytes (data not shown).
Correlation between expression of TLR2/TLR4 and proinflammatory molecules. Table 2 shows 
the correlation between TLR2/TLR4 expression in neutrophils and monocytes with the levels of proinflamma-
tory markers. We found a strong correlation between TLR2 expression in both monocytes and neutrophils (all 
p < 0.0001) and TLR4 in monocytes (all p < 0.05) with serum levels of IL-1B, IL-6, TNF-α and MMP-9. However, 
we only found a correlation with MMP-9 serum levels (p = 0.034) for TLR4 expression in neutrophils.
Controls n = 20 Keratoconus n = 40 p
Age (years) 30.4 ± 7.6 33.1 ± 10.9 0.276
Male (%) 55 55 0.609
Allergic disease (%) 30 60 0.028
Family history of KC 0 25 0.001
K2 (diopters) 43.4 ± 1.2 54.3 ± 5.9 <0.0001
Thinnest point (μm) 534.2 ± 32.1 410.5 ± 61.1 <0.0001
TLR2 neutrophils (AFU) 539.2 ± 114.8 718.8 ± 92.3 <0.0001
TLR2 monocytes (AFU) 2222.5 ± 415.8 2837.6 ± 487.1 <0.0001
TLR4 neutrophils (AFU) 480.1 ± 129.8 678.9 ± 116.2 <0.0001
TLR4 monocytes (AFU) 1033.6 ± 111.4 1613.4 ± 277.8 <0.0001
IL-1β (pg/mL) 63.0 ± 38.1 123.9 ± 53.8 <0.0001
IL-6 (pg/mL) 75.9 ± 41.6 112.4 ± 29.6 <0.0001
TNF-α (pg/mL) 35.9 ± 24.5 93.2 ± 59.0 <0.0001
MMP-9 (ng/mL) 16.8 ± 3.8 25.9 ± 6.4 <0.0001
NF-κB (∆Ct) 5.9 ± 4.8 3.0 ± 4.4 0.036
Table 1. Clinical characteristics, topographic variables, biochemical parameters and TLR expression in patients 
with keratoconus and control subjects. IL = interleukin; K2 = steep meridian; KC = keratoconus; MMP-9 = matrix 
metalloproteinase 9; NF-κB = nuclear factor-kappa B; TNF-α = tumor necrosis factor alpha; TLR = Toll-like receptor.
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Regarding NF-κB, we found a strong correlation with TLR2 expression in neutrophils (r = 0.381; p = 0.006) 
and monocytes (r = 0.813; p < 0.0001), as well as a weak correlation with TLR4 expression in neutrophils 
(r = 0.095; p = 0.034) (Fig. 3).
On the other hand, due to KC patients showed more frequent history of allergy disease compared to the 
control group, we performed a multiple linear regression analysis, adjusted by allergic disease, in order to 
analyze the independent influence of TLR2/TLR4 expression in monocytes and neutrophils on NF-κB levels, 
the main proinflammatory factor induced by TLRs. As shown in Table 3, no effects were observed for allergic 
disease.
Figure 1. TLR2/TLR4 expression levels in neutrophils/monocytes by study groups. Values represent the 95% 
CI for mean. ***p < 0.0001 compared to controls.
Figure 2. Expression levels of inflammatory markers by study groups. Values represent the 95% CI for mean. 
*p < 0.05; ***p < 0.0001 compared to controls.
TLR2 neutrophils TLR2 monocytes TLR4 neutrophils TLR4 monocytes
IL-1β 0.695 (p < 0.0001) 0.737 (p < 0.0001) 0.183 (p = 0.161) 0.269 (p = 0.038)
IL-6 0.535 (p < 0.0001) 0.614 (p < 0.0001) 0.237 (p = 0.069) 0.328 (p = 0.010)
TNF-α 0.583 (p < 0.0001) 0.829 (p < 0.0001) 0.089 (p = 0.501) 0.272 (p = 0.036)
MMP-9 0.594 (p < 0.0001) 0.724 (p < 0.0001) 0.275 (p = 0.034) 0.442 (p < 0.0001)
Table 2. Correlation between TLR2/TLR4 expression in neutrophils and monocytes with levels of 
proinflammatory markers. IL = interleukin; KC = keratoconus; MMP-9 = matrix metalloproteinase 9; 
TLR = Toll-like receptor; TNF-α = Tumor necrosis factor alpha.
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Discussion
This cross-sectional case-control study has evaluated the expression of TLR2 and TLR4 in monocytes and neu-
trophils from KC patients compared with control subjects. Remarkably, TLR2 and TLR4 expression in both 
neutrophils and monocytes was significantly higher in patients with KC compared to control subjects, but the 
correlation with TLR4 was less robust compared to TLR2. In addition, we found a strong correlation between 
TLR2 expression in both monocytes and neutrophils and TLR4 in monocytes with serum levels of IL-1B, IL-6, 
TNF-α, MMP-9 and NF-κB expression. By contrast, no correlation was found between the expression of TLR2 
and TLR4 in neutrophils and monocytes with the severity of KC, evaluated by K2 and the thinnest point of the 
cornea.
Despite extensive basic and clinical studies of KC in recent years, the precise mechanisms underlying this 
pathology still remain unknown. Pathophysiologic components of KC can be largely classified into the follow-
ing: alterations of the stroma composition, imbalance of pro-inflammatory and anti-inflammatory molecules, 
imbalance of the enzymes that cause extracellular matrix degradation and their corresponding inhibitors, oxi-
dative stress, and cellular hypersensivity. These events occur simultaneously, but it is yet unclear which precedes 
the other and which events are necessary for the evolution of the disease12. In this regard, several clinical stud-
ies of KC support the idea that its pathogenesis may involve an immune and inflammatory component4–6,12–15. 
Interestingly, more recent studies demonstrate that molecular changes associated to KC can be reflected sys-
temically, as it has been shown with oxidative stress16–19. These findings are in line with our results, which show 
that an inflammatory and innate immune response occurs systemically in KC patients. Supporting this claim, 
there is accumulating evidence that systemic inflammatory changes on oxidative stress may affect the corneal 
microenvironment in KC20. Accordingly, systemic inflammation monitored via the neutrophil-to-lymphocyte 
Figure 3. Correlations between NF-kB and TLR2/TLR4 expression levels in neutrophils/monocytes.
B (CI 95%), p Unadjusted model B (CI 95%), p Adjusted model*
TLR2 neutrophils 200.1 (138.9–261.3), <0.0001 181.8 (119.7–243.7), <0.0001
TLR2 monocytes 777.4 (448.4–1106.4), <0.0001 701.7 (362.9–1040.4), <0.0001
TLR4 neutrophils 188.1 (117.4–258.9), <0.0001 191.9 (117.6–266.3), <0.0001
TLR4 monocytes 559.9 (410.6–709.4), <0.0001 567.8 (410.7–724.9), <0.0001
Table 3. B estimate of TLR2/TLR4 expression in neutrophils and monocytes for NF-kB. Note that due to the 
collinearity between the TLR2 and TRL4, the influence of each of them on NF-kB expression was assessed in a 
separate multiple linear regression model. *Adjusted by allergic disease; TLR = Toll-like receptor.
www.nature.com/scientificreports/
5SCIeNTIFIC REpoRTS | 7: 12975  | DOI:10.1038/s41598-017-13525-7
ratio was recently associated with progressive KC19, and systemic oxidative stress has been also reported in KC 
patients17. Increased frequency of neutrophils indicates proinflammatory conditions, and neutrophils are directly 
associated with the activation of MMPs, which have been found to be elevated in KC4,5,19. Moreover, previous 
studies by our group and others have demonstrated that inflammatory markers, such as IL-6, TNF-α and MMP-9 
are significantly increased in tears of patients with KC4,5,21–24. We also observed decreased levels of Lf, IGKC and 
ZAG in the tears of patients with KC compared to control subjects6. On the other hand, it has been described the 
effects of cyclosporin A in reducing MMP9 and inhibiting inflammation to halt progression of KC25. These results 
suggest that inflammatory and immunological processes may be involved in the pathogenesis of KC, even more 
when these biomarkers were associated with the severity of the KC4–6,26. The results of the present study showed 
that TLR2 and TLR4 expression in both neutrophils and monocytes was significantly higher in patients with 
KC compared to control subjects; and that patients with KC also had higher serum levels of IL-1B, IL-6, TNF-α, 
MMP-9 and NF-κB. In addition, a strong correlation was found between TLR2 expression in both monocytes and 
neutrophils and TLR4 in monocytes with serum levels of IL-1B, IL-6, TNF-α, MMP-9 and NF-κB expression. 
Consequently, it is tempting to postulate that such inflammatory response could be a consequence of the TLR 
activation. In fact, previous studies have shown that the treatment of corneal epithelial cells with neutralizing 
TLR2- antibodies induced a significant decrease of IL-6, IL-8 and TNF-α levels11. Additionally, the preocular tear 
film contains numerous specific and nonspecific immune components, which include cytokines and cell adhesion 
molecules27; and several cell types, including keratocytes, express IL-6 in response to a stimulation by IL-1β or 
TNF-α28; and TLRs increase secretion of IL-6 and TNF-α in corneal fibroblasts29.
Although no association was found between TLR2 and TLR4 expression in neutrophils and monocytes and 
the severity of KC, the fact that the expression of TLRs is strongly associated with systemic levels of proinflamma-
tory molecules indicates that innate immunity may be involved in the pathophysiology of KC since increased lev-
els of IL-6, TNF-α and MMP-9 in tears were associated with the degree of KC evolution. Moreover, as previously 
mentioned, systemic inflammation monitored via the neutrophil-to-lymphocyte ratio was recently associated 
with progressive KC19.
This study has some limitations. Firstly, in our study, KC patients and/or control subjects with immunological 
diseases, including autoimmune diseases, were excluded, and a higher incidence of KC was reported in immune 
disorders30,31. This fact may be excluding potential results on new insights or pathways regarding the association 
between immune response and KC. However, the inclusion of patients and controls with allergic asthma, atopic 
dermatitis and allergic rhinitis somehow mitigates this limitation, even more so when the allergy variable was 
included in the different analyzes performed in the study.
In conclusion, this study reveals that TLR2 and TLR4 in monocytes and neutrophils are overexpressed in KC 
patients compared to control subjects. Moreover, this overexpression of TLR2/TLR4 is associated to increased 
serum levels of inflammatory mediators such as NF-kB, IL-6, IL-1B, TNF-α, MMP-9. These results suggest that 
TLRs may play an important role in the pathophysiology of KC.
Methods
Patients. We have designed a cross-sectional, case-control study in which 40 patients with bilateral KC (55% 
male; mean age, 31.1 ± 10.9 years) and 20 control subjects (55% male; mean age, 30.4 ± 7.6 years), without KC 
clinical or topographic signs, were enrolled. All KC patients and control subjects were specifically cited for the 
purposes of this study, and all examinations were performed by the same researcher. Collected data included sex, 
age, patient’s ocular history, medical history (allergy, eye rubbing), and family history of KC. We have considered 
allergic conditions the following: allergic asthma, atopic dermatitis, and/or allergic rhinitis. This research was car-
ried out in accordance with the Declaration of Helsinki of the World Medical Association (2008) and approved by 
the Ethics Committee of Research at Servizo Galego de Saúde. Informed consent was obtained from each patient 
or control subject after full explanation of the procedures.
Inclusion criteria were the following: 1) Patients with bilateral KC with biomicroscopic signs in both eyes, such 
as Vogt striae, Fleischer ring, and prominent corneal nerves. Rabinowitz/McDonnell criterion was used for the 
KC diagnosis32,33, and tomographic parameters; 2) Control subjects with normal corneal topography maps and 
without biomicroscopic signs of KC.
Exclusion criteria included the following: 1) previous surgical intervention in the anterior segment, or past 
history of corneal trauma or any other corneal pathology; 2) existence of active systemic or ocular inflamma-
tion, and current treatment with systemic or local anti-inflammatory drugs; 3) hepatic, renal, hematologic, and 
immunologic diseases, disorders of thyroid function, uncontrolled diabetes, infections in the days preceding to 
the sample collection and solid tumors; since they may interfere with the results of the study of molecular markers 
of innate immunity.
The biomicroscopy exam was performed to detect signs of KC and the corneal topography study was per-
formed to quantify topographic parameters. The modified Rabinowitz-McDonnell test was used to confirm the 
diagnosis of KC32,33, and the severity of KC was classified according to the steepest simulated keratometry reading 
(K2) on the keratometric map (K2 < 45 D, mild; K2 between 45 and 52 D, moderate; K2 > 52 D, severe KC)4,34. 
Quantitative topographic parameters were analysed: steep, flat and average keratometry (K) values, 3 mm irreg-
ularity, 5 mm irregularity; and tomographic parameters: posterior elevation and the thinnest point pachymetry 
of the cornea.
Ophthalmological Instruments. Basic examination instruments were a Topcon SL-2 biomicroscope, 
Topcon IS-600 refraction column with trial lenses set, and alphabetic Snellen visual acuity test. As specific exam-
ination instruments we used a TOPCON CA-100 topographer (Topcon Medical Systems, Inc., NJ, USA) for 
corneal topography; and an Orbscan IIz (Orbtek, Utah, USA) for corneal pachymetry and posterior elevation.
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TLR2 and TLR4 expression analysis. TLR2 and 4 expression analyses were performed by flow cytometry 
in blood samples, withdrawn from all KC patients and control subjects, collected in EDTA-anticoagulated tubes. 
For the expression analysis of TLR2 and TLR4, monocytes, lymphocytes and neutrophils were separated by their 
forward and side scattering signal characteristics. Fluorescein isothiocyanate (FITC) anti-TLR2-conjugated mon-
oclonal antibodies (IMMUNOSTEP, Salamanca, Spain) and phycoerythrin (PE) anti-TLR4 conjugated monoclo-
nal antibodies (IMMUNOSTEP, Salamanca, Spain) were used to quantify TLR expression. Samples were analyzed 
on a FACSAria iiu flow cytometer (BD Biosciences, NJ, USA). Cell fluorescence was measured immediately after 
staining, and data were analyzed with the use of FACSDiva software (BD Biosciences, NJ, USA). Mean expression 
of TLR2 and TLR4 in monocytes and neutrophils was expressed as AFU (arbitrary fluorescence units).
Laboratory Test. Blood samples were collected in chemistry test tubes, centrifuged at 3000 g for 15 minutes, 
and immediately frozen and stored at −80 °C. IL-1β, IL-6 and TNF-α serum levels were measured by using 
an immunodiagnostic IMMULITE 1000 System (Siemens Healthcare Global, Los Angeles, CA, USA). On the 
other hand, serum levels of active MMP-9 (GE Healthcare, Amersham, UK, Little Chalfont, Buckinghamshire, 
UK) were measured using commercial ELISA kits following manufacturer’s instructions. The intra-assay and 
inter-assay coefficients of variation (CV) for all molecular markers were <8%. Determinations were performed 
in a laboratory blinded to clinical and topographic data.
NF-kB expression analysis. Expression of NF-κB was analyzed by rq-PCR on a Mx3005p system from 
Stratagene (Thermo Scientific, Waltham, MA, USA). For this analysis, RNA was extracted from 200 μL of EDTA 
anticoagulated blood sample, with a semiautomatic robot MagnaPure Compact (Roche Diagnostics, Basel, 
Switzerland). RNA extracts were quantified with a Nanodrop system (Thermo Scientific, Waltham, MA, USA) 
and cDNA was synthesized for each sample using the High Capacity RNA to cDNA kit (Applied Biosystems, 
Thermo Scientific, Waltham, MA, USA) according to the provided instructions in a thermocycler T Professional 
(Biometra GmbH, Göttingen, Germany). rq-PCR was performed with commercially available specific primers 
and probes for NF-κB (Applied Biosystems, Thermo Scientific, Waltham, MA, USA). NF-κB amplifications were 
simultaneously performed with a GAPDH amplification, which was used as loading control. Following rq–PCR, 
quantification of gene expression was made by determining the Ct (for PCR cycle in what amplification it starts, 
these units are inverse to the NF-κB quantity), based on fluorescence detection, within the geometric region of 
the semilog view of the amplification plot. Relative quantization of target gene expression was evaluated using the 
comparative Ct method as previously described by Ross et al.35. The ΔCt value was determined by subtracting the 
target Ct of each sample from its respective GAPDH Ct value.
Statistical analysis. Sample size was calculated by using the statistical EPIDAT 3.1 software (http://www.
sergas.es/MostrarContidos_N3_T01.aspx?IdPaxina=62714), considering that TLR2/TLR4 expression in KC 
patients is >25% compared to control subjects. The minimum calculated sample size was 40 patients with KC and 
20 control subjects in order to obtain a statistical power of 80% with a significant difference level of 0.05.
Results were expressed as percentages for categorical variables and as mean (standard deviation) or median 
and range (25th and 75th percentiles) for the continuous variables depending on whether their distribution was 
normal or not. The Kolmogorov-Smirnov test was used for testing the normality of the distribution. Proportions 
were compared using the chi-square or Fisher test, while the continuous variables between groups were compared 
with the Student’s t or the Mann-Whitney tests depending on whether their distribution was normal or not, 
respectively. Bivariate correlations were performed using Pearson’s (normally distributed variables) or Spearman 
(variables without normal distribution) coefficients.
The independent influence of TLR2/TLR4 expression in monocytes and neutrophils on NF-κB levels was 
assessed by multiple linear regression models. This multivariable linear regression model was adjusted by allergic 
disease. Results were expressed as Beta estimate with the corresponding 95% confidence intervals (95% CI). A 
p-value < 0.05 was considered to be statistically significant in all tests. The statistical analysis was conducted in 
SPSS 20.0 (IBM, Chicago, IL, USA) for Mac.
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